Description

Send us a text

In our Season 11 opening episode, we’re bringing you the latest updates from the 2025 ASCO Annual Meeting on metastatic breast cancer. Dr. Ashley Schreier, breast oncologist at Weill Cornell Medicine, breaks down key research and explains what it could mean for people living with MBC.

Topics include:

• Research results for hormone therapy options like camizestrant
• The role of ESR1 mutation testing
• Results from treatment combinations like Enhertu and Perjeta, and Trodelvy and Keytruda
• How to navigate clinical trial access
• Tips for staying hopeful while exploring treatment options

Whether you’re a patient, caregiver, or advocate, this episode is packed with insights to help you stay informed and empowered.